Company / Net Income
Alaunos Therapeutics, Inc. Net Income History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$4.7M
FY2025
5-year range
-$80.0M / -$4.7M
FY2021-FY2025
Trend
+86.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has increased for 4 consecutive years, from -$80M in FY2021 to -$5M in FY2025.
Based on SEC 10-K filings.
-$5M in FY2025.
Improved from -$38M to -$5M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Alaunos Therapeutics, Inc.'s net income has grown for 4 consecutive years.
- In FY2025, net income increased 86.7% year-over-year.
- Peak net income was recorded in FY2012.
- Lowest net income in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -3.79 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.7M | +86.7% |
| FY2024 | -$35.1M | +6.9% |
| FY2023 | -$37.7M | +52.1% |
| FY2022 | -$78.8M | +1.5% |
| FY2021 | -$80.0M | -50.6% |
| FY2020 | -$53.1M | +2.2% |
| FY2019 | -$54.3M | +67.1% |
| FY2018 | -$165.3M | -2806.6% |
| FY2013 | -$5.7M | -3454.4% |
| FY2012 | -$160.0K | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026